Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
This page is not indexed by search engines while we improve data quality.
Scott Mark E — Human Necessities
Scott Mark E holds 6 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Scott Mark E |
| Technology | Human Necessities |
| Patents in slice | 6 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2016 |
Representative patents
Notable publications linking Scott Mark E to Human Necessities.
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Recent filings
Latest patents from Scott Mark E in Human Necessities.
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Pyrrolidine derived beta 3 adrenergic receptor agonists
US-9486448-B2 · Nov 8, 2016 · US
Related pages
Navigate to parent entity pages.